NCT06918145View on ClinicalTrials.gov

Clinical Study on Lymphaticovenous Anastomosis（LVA） for the Treatment of Alzheimer's Disease（AD）

NAEnrolling by invitationINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 2, 2025

Primary Completion Date

March 1, 2030

Study Completion Date

March 1, 2030

Conditions
Alzheimer&Amp;#39;s Disease (AD)
Interventions
PROCEDURE

Lymphaticovenous Anastomosis

The basic principle of LVA surgery is to anastomose the deep cervical lymphatic vessels of the brain with adjacent small veins, effectively enabling the direct reflow of accumulated Aβ and tau proteins in the brain's lymphatic circulation into the venous system, thereby improving the symptoms of Alzheimer's Disease (AD).

Trial Locations (1)

100191

Peking university third hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER